49 Search Results for Lymphoma

Department of Veterans Affairs

Incidence of NK/T-cell Lymphoma Rises Significantly in the United States

Limited data are available regarding the incidence, survival patterns, and long-term outcomes of natural killer/T-cell neoplasms in the United States.

August 19, 2018
AIDS

Early Therapy Helps Prevent Non-Hodgkin lymphoma, Other AIDS-related Cancer

Prevention of AIDS-defining cancers, such as non-Hodgkin lymphoma, can be helped by early, sustained antiretroviral therapy, which results in long-term viral suppression, a new study found.

August 19, 2018
Agent Orange

New Therapy Options Recently Approved for Hodgkin’s Lymphoma

While the availability of novel therapies is making the future brighter for non-Hodgkin’s lymphoma (NHL) patients, new treatments also are coming on line for Hodgkin’s lymphoma, which is a hematological cancer distinct from NHL.

June 12, 2018
Hematology

Maintenance Rituximab Increases Survival in Follicular Lymphoma

Because several studies have suggested it fails to increase overall survival (OS) despite prolonging progression-free survival (PFS), use of maintenance rituximab (MR) following chemoimmunotherapy in follicular lymphoma (FL) remains controversial.

June 7, 2018
Bleomycin

Pulmonary Events Affect 30% of Hodgkin Lymphoma Patients Post-Chemo

Bleomycin, the first line standard of care for Hodgkin lymphoma causes pulmonary events in some patients, but physicians have been uncertain how many patients are affected and how long they remain at risk.

June 1, 2018

Optimizing Treatment of Peripheral T-cell Lymphoma

Long-term survival in patients with aggressive peripheral T-cell lymphoma (PTCL) is generally poor, no clear consensus exists on optimal initial therapy, according to a new study.

December 15, 2017
featured-2

Treatment Options Multiply for Cutaneous T-cell Lymphoma

After decades on the sidelines, research in cutaneous T-cell lymphoma (CTCL) has exploded in recent years, bringing patients with this rare disease new opportunities for treatment.

October 16, 2017

Study Looks for Patterns in Lymphoma Relapse

PORTLAND, OR—High response rates can be achieved with first-line high-dose methotrexate (HD-MTX) based regimens for primary central nervous system lymphoma (PCNSL), but many patients relapse within two years of diagnosis, according to a study in... View Article

August 16, 2017

Lymphoma, Other Cancers Linked to HCV

Hepatitis C virus (HCV) infection is known to cause hepatocellular carcinoma (HCC) and subtypes of non-Hodgkin lymphoma (NHL).

May 19, 2017

Impetigo, Psoriasis Might Increase Cutaneous T-Cell Lymphoma Risk

Recent research has focused on some etiological factors to help predict who is at risk for developing cutaneous T-cell lymphoma (CTCL), which occurs disproportionately in veterans.

October 12, 2016

Genomic Research Identifies Possible Therapeutic Targets for Cutaneous T-Cell Lymphoma

Presumptively caused by Agent Orange exposure, cutaneous T-cell lymphoma occurs disproportionately among male veterans. Complicating the clinical approach, the disorders comprising CTCL are similar but differ greatly in response to therapy. New genomic research on the rare cancer, however, is holding out promise for better, more-customized treatment.

June 1, 2016

Lymphoma Survivors Should Be Monitored for Melanoma

ROCKVILLE, MD — While previous studies have reported that survivors of non-Hodgkin lymphoma (NHL) have an increased risk of developing cutaneous melanoma, risks associated with specific treatments and immune-related risk factors have not been quantified.To... View Article

May 6, 2016

Disrupted Metabolism Affects Lymphoma Development

SAN ANTONIO — New research directly links disrupted metabolism to a common and often fatal type of lymphoma, according to an article in Nature Communications.1“The link between metabolism and cancer has been proposed or inferred... View Article

May 6, 2016

VA Tops in Experience With Rare Lymphomas, Looks for More Effective Treatments

As the healthcare system with the most experience treating older men, the VA has special expertise in treating uncommon diseases that plague them, such as peripheral T-cell lymphoma. The current challenge for clinicians is to... View Article

June 8, 2015

Rare Lymphoma Challenges VA Clinicians from Diagnosis to Treatment

An estimated 5-10% of all cutaneous T-cell lymphoma (CTCL) diagnosed each year occurs in veterans treated by the VA. The cancer, classified as presumptively caused by Agent Orange exposure, is notoriously difficult to diagnose and... View Article

May 21, 2014
Agent Orange

Despite Unanimous House Support, VA Opposes ‘Blue Water’ Legislation

VA officials told lawmakers last month that it opposes a bill that would expand the presumption of Agent Orange exposure to Vietnam veterans who served offshore because the "science is not there."

September 9, 2018
blood cancers

Memory Problems Worsen Survival Rates in Older Blood Cancer Patients

About a third of hematologic cancer patients in a recent cohort study screened positive for executive dysfunction, and more than 17% had memory problems.

August 12, 2018
Agent Orange Benefits

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.

June 22, 2018
Agent Orange

CTCL 6-10 Times More Common in Veterans; Agent Orange a Factor New Therapies Raise Optimism about Treatment

Chances are, if you haven’t trained or practiced at the VA, you haven’t seen cutaneous T-cell lymphoma (CTCL), a form of non-Hodgkin lymphoma.

June 12, 2018
Cognitive Dysfunction

Cognitive Dysfunction Affects Blood Cancer Survival

BOSTON — With an aging population, cognitive impairment is increasingly common. The question raised by a new study was what effect that has on survival for older patients with hematologic cancers.

April 14, 2018